A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00786201
Recruitment Status : Completed
First Posted : November 6, 2008
Last Update Posted : December 28, 2015
Information provided by (Responsible Party):
Centocor, Inc.